Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Pregnancy Epigenetic Signature in T Helper 17 and T Regulatory Cells in Multiple Sclerosis.

Iannello A, Rolla S, Maglione A, Ferrero G, Bardina V, Inaudi I, De Mercanti S, Novelli F, D'Antuono L, Cardaropoli S, Todros T, Turrini MV, Cordioli C, Puorro G, Marsili A, Lanzillo R, Brescia Morra V, Cordero F, De Bortoli M, Durelli L, Visconti A, Cutrupi S, Clerico M.

Front Immunol. 2019 Jan 8;9:3075. doi: 10.3389/fimmu.2018.03075. eCollection 2018.

2.

Normative values of the Rao's Brief Repeatable Battery in an Italian young adolescent population: the influence of age, gender, and education.

Falco F, Moccia M, Chiodi A, Carotenuto A, D'Amelio A, Rosa L, Piscopo K, Falco A, Costabile T, Lauro F, Brescia Morra V, Lanzillo R.

Neurol Sci. 2019 Jan 15. doi: 10.1007/s10072-019-3712-3. [Epub ahead of print]

PMID:
30645750
3.

Therapeutic lag in reducing disability progression in relapsing-remitting multiple sclerosis: 8-year follow-up of two randomized add-on trials with atorvastatin.

Lanzillo R, Moccia M, Russo CV, Carotenuto A, Nozzolillo A, Petruzzo M, Palladino R, Chataway J, Brescia Morra V.

Mult Scler Relat Disord. 2019 Jan 2;28:193-196. doi: 10.1016/j.msard.2018.12.042. [Epub ahead of print]

PMID:
30623857
4.

MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in Multiple Sclerosis.

Cocozza S, Pontillo G, Lanzillo R, Russo C, Petracca M, Di Stasi M, Paolella C, Vola EA, Criscuolo C, Moccia M, Lamberti A, Monti S, Brescia Morra V, Elefante A, Palma G, Tedeschi E, Brunetti A.

Neuroradiology. 2019 Feb;61(2):155-162. doi: 10.1007/s00234-018-02150-4. Epub 2019 Jan 8.

PMID:
30617409
5.

Brain tissue volumes and relaxation rates in multiple sclerosis: implications for cognitive impairment.

Megna R, Alfano B, Lanzillo R, Costabile T, Comerci M, Vacca G, Carotenuto A, Moccia M, Servillo G, Prinster A, Brescia Morra V, Quarantelli M.

J Neurol. 2019 Feb;266(2):361-368. doi: 10.1007/s00415-018-9139-6. Epub 2018 Nov 29.

PMID:
30498912
6.

Evaluation of optic nerve subarachnoid space in primary open angle glaucoma using ultrasound examination.

Cennamo G, Montorio D, Breve MA, Brescia Morra V, Menna F, Cennamo G.

PLoS One. 2018 Nov 28;13(11):e0208064. doi: 10.1371/journal.pone.0208064. eCollection 2018.

7.

Authors' Response to the Letter to the Editor Regarding: A Comprehensive Review on Copemyl®.

Annovazzi P, Bertolotto A, Brescia Morra V, Gasperini C, Montanari E, Navarra P, Patti F, Pia Sormani M, Ghezzi A.

Neurol Ther. 2018 Dec;7(2):391-393. doi: 10.1007/s40120-018-0116-x. Epub 2018 Nov 10. No abstract available.

8.

Absence of infratentorial lesions in Fabry disease contributes to differential diagnosis with multiple sclerosis.

Ugga L, Cocozza S, Pontillo G, Russo C, Brescia Morra V, Lanzillo R, Riccio E, Pisani A, Brunetti A.

Brain Behav. 2018 Nov;8(11):e01121. doi: 10.1002/brb3.1121. Epub 2018 Oct 2.

9.

Olfactory function and cognition in relapsing-remitting and secondary-progressive multiple sclerosis.

Carotenuto A, Costabile T, Moccia M, Falco F, Scala MR, Russo CV, Saccà F, De Rosa A, Lanzillo R, Brescia Morra V.

Mult Scler Relat Disord. 2019 Jan;27:1-6. doi: 10.1016/j.msard.2018.09.024. Epub 2018 Sep 22.

PMID:
30273697
10.

Reduced Intracranial Volume in Fabry Disease: Evidence of Abnormal Neurodevelopment?

Pontillo G, Cocozza S, Brunetti A, Brescia Morra V, Riccio E, Russo C, Saccà F, Tedeschi E, Pisani A, Quarantelli M.

Front Neurol. 2018 Aug 17;9:672. doi: 10.3389/fneur.2018.00672. eCollection 2018.

11.

Pragmatic abilities in multiple sclerosis: The contribution of the temporo-parietal junction.

Carotenuto A, Cocozza S, Quarantelli M, Arcara G, Lanzillo R, Brescia Morra V, Cerillo I, Tedeschi E, Orefice G, Bambini V, Brunetti A, Iodice R.

Brain Lang. 2018 Oct;185:47-53. doi: 10.1016/j.bandl.2018.08.003. Epub 2018 Aug 12.

PMID:
30110668
12.

Retinal vascular density in multiple sclerosis: a 1-year follow-up.

Lanzillo R, Cennamo G, Moccia M, Criscuolo C, Carotenuto A, Frattaruolo N, Sparnelli F, Melenzane A, Lamberti A, Servillo G, Tranfa F, De Crecchio G, Brescia Morra V.

Eur J Neurol. 2019 Jan;26(1):198-201. doi: 10.1111/ene.13770. Epub 2018 Sep 3.

PMID:
30102834
13.

Cerebellum and cognition in progressive MS patients: functional changes beyond atrophy?

Cocozza S, Pontillo G, Russo C, Russo CV, Costabile T, Pepe A, Tedeschi E, Lanzillo R, Brescia Morra V, Brunetti A, Inglese M, Petracca M.

J Neurol. 2018 Oct;265(10):2260-2266. doi: 10.1007/s00415-018-8985-6. Epub 2018 Jul 28.

PMID:
30056570
14.

Striatonigral involvement in Fabry Disease: A quantitative and volumetric Magnetic Resonance Imaging study.

Russo C, Pontillo G, Pisani A, Saccà F, Riccio E, Macera A, Rusconi G, Stanzione A, Borrelli P, Brescia Morra V, Tedeschi E, Brunetti A, Cocozza S, Palma G.

Parkinsonism Relat Disord. 2018 Dec;57:27-32. doi: 10.1016/j.parkreldis.2018.07.011. Epub 2018 Jul 21.

PMID:
30054181
15.

Teeth loss after teriflunomide treatment: Casual or causal? A short case series.

Vacchiano V, Frattaruolo N, Mancinelli L, Foschi M, Carotenuto A, Scandellari C, Piattelli M, Brescia Morra V, Lugaresi A.

Mult Scler Relat Disord. 2018 Aug;24:120-122. doi: 10.1016/j.msard.2018.06.018. Epub 2018 Jun 30.

PMID:
29982109
16.

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks.

Portaccio E, Annovazzi P, Ghezzi A, Zaffaroni M, Moiola L, Martinelli V, Lanzillo R, Brescia Morra V, Rinaldi F, Gallo P, Tortorella C, Paolicelli D, Pozzilli C, De Giglio L, Cavalla P, Cocco E, Marrosu MG, Patti F, Solaro C, Bellantonio P, Uccelli A, Laroni A, Pastò L, Giannini M, Trojano M, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

Neurology. 2018 Mar 6;90(10):e823-e831. doi: 10.1212/WNL.0000000000005067. Epub 2018 Feb 7.

PMID:
29438046
17.

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks.

Portaccio E, Moiola L, Martinelli V, Annovazzi P, Ghezzi A, Zaffaroni M, Lanzillo R, Brescia Morra V, Rinaldi F, Gallo P, Tortorella C, Paolicelli D, Pozzilli C, De Giglio L, Cavalla P, Cocco E, Marrosu MG, Solaro C, Uccelli A, Laroni A, Pastò L, Giannini M, Trojano M, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

Neurology. 2018 Mar 6;90(10):e832-e839. doi: 10.1212/WNL.0000000000005068. Epub 2018 Feb 7.

PMID:
29438041
18.

Default mode network modifications in Fabry disease: A resting-state fMRI study with structural correlations.

Cocozza S, Pontillo G, Quarantelli M, Saccà F, Riccio E, Costabile T, Olivo G, Brescia Morra V, Pisani A, Brunetti A, Tedeschi E; AFFINITY study group.

Hum Brain Mapp. 2018 Apr;39(4):1755-1764. doi: 10.1002/hbm.23949. Epub 2018 Jan 9.

PMID:
29315984
19.

Cardiovascular profile improvement during Natalizumab treatment.

Moccia M, Albero R, Lanzillo R, Saccà F, De Rosa A, Russo CV, Carotenuto A, Palladino R, Brescia Morra V.

Metab Brain Dis. 2018 Jun;33(3):981-986. doi: 10.1007/s11011-017-0169-z. Epub 2017 Dec 18.

20.

Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration.

La Rocca C, Carbone F, De Rosa V, Colamatteo A, Galgani M, Perna F, Lanzillo R, Brescia Morra V, Orefice G, Cerillo I, Florio C, Maniscalco GT, Salvetti M, Centonze D, Uccelli A, Longobardi S, Visconti A, Matarese G.

Metabolism. 2017 Dec;77:39-46. doi: 10.1016/j.metabol.2017.08.011. Epub 2017 Sep 8.

21.

A 8-year retrospective cohort study comparing Interferon-β formulations for relapsing-remitting multiple sclerosis.

Moccia M, Palladino R, Carotenuto A, Saccà F, Russo CV, Lanzillo R, Brescia Morra V.

Mult Scler Relat Disord. 2018 Jan;19:50-54. doi: 10.1016/j.msard.2017.11.006. Epub 2017 Nov 6.

PMID:
29128737
22.

Social Media and Multiple Sclerosis in the Posttruth Age.

Lavorgna L, Lanzillo R, Brescia Morra V, Abbadessa G, Tedeschi G, Bonavita S.

Interact J Med Res. 2017 Sep 27;6(2):e18. doi: 10.2196/ijmr.7879.

23.

Optical coherence tomography angiography retinal vascular network assessment in multiple sclerosis.

Lanzillo R, Cennamo G, Criscuolo C, Carotenuto A, Velotti N, Sparnelli F, Cianflone A, Moccia M, Brescia Morra V.

Mult Scler. 2018 Nov;24(13):1706-1714. doi: 10.1177/1352458517729463. Epub 2017 Sep 21.

PMID:
28933233
24.

Immunometabolic profiling of patients with multiple sclerosis identifies new biomarkers to predict disease activity during treatment with interferon beta-1a.

Lanzillo R, Carbone F, Quarantelli M, Bruzzese D, Carotenuto A, De Rosa V, Colamatteo A, Micillo T, De Luca Picione C, Saccà F, De Rosa A, Moccia M, Brescia Morra V, Matarese G.

Clin Immunol. 2017 Oct;183:249-253. doi: 10.1016/j.clim.2017.08.011. Epub 2017 Aug 18.

PMID:
28823971
25.

Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study).

Messina S, Solaro C, Righini I, Bergamaschi R, Bonavita S, Bossio RB, Brescia Morra V, Costantino G, Cavalla P, Centonze D, Comi G, Cottone S, Danni MC, Francia A, Gajofatto A, Gasperini C, Zaffaroni M, Petrucci L, Signoriello E, Maniscalco GT, Spinicci G, Matta M, Mirabella M, Pedà G, Castelli L, Rovaris M, Sessa E, Spitaleri D, Paolicelli D, Granata A, Zappia M, Patti F; SA.FE. study group.

PLoS One. 2017 Aug 1;12(8):e0180651. doi: 10.1371/journal.pone.0180651. eCollection 2017.

26.

A Comprehensive Review on Copemyl®.

Annovazzi P, Bertolotto A, Brescia Morra V, Gasperini C, Montanari E, Navarra P, Patti F, Sormani MP, Ghezzi A.

Neurol Ther. 2017 Dec;6(2):161-173. doi: 10.1007/s40120-017-0079-3. Epub 2017 Jul 31. Review.

27.

Health-Related Coping and Social Interaction in People with Multiple Sclerosis Supported by a Social Network: Pilot Study With a New Methodological Approach.

Lavorgna L, Russo A, De Stefano M, Lanzillo R, Esposito S, Moshtari F, Rullani F, Piscopo K, Buonanno D, Brescia Morra V, Gallo A, Tedeschi G, Bonavita S.

Interact J Med Res. 2017 Jul 14;6(2):e10. doi: 10.2196/ijmr.7402.

28.

Brain Susceptibility Changes in a Patient with Natalizumab-Related Progressive Multifocal Leukoencephalopathy: A Longitudinal Quantitative Susceptibility Mapping and Relaxometry Study.

Pontillo G, Cocozza S, Lanzillo R, Borrelli P, De Rosa A, Brescia Morra V, Tedeschi E, Palma G.

Front Neurol. 2017 Jun 19;8:294. doi: 10.3389/fneur.2017.00294. eCollection 2017.

29.

CD4/CD8 ratio during natalizumab treatment in multiple sclerosis patients.

Carotenuto A, Scalia G, Ausiello F, Moccia M, Russo CV, Saccà F, De Rosa A, Criscuolo C, Del Vecchio L, Brescia Morra V, Lanzillo R.

J Neuroimmunol. 2017 Aug 15;309:47-50. doi: 10.1016/j.jneuroim.2017.05.006. Epub 2017 May 12.

PMID:
28601287
30.

Dimethyl fumarate mediates Nrf2-dependent mitochondrial biogenesis in mice and humans.

Hayashi G, Jasoliya M, Sahdeo S, Saccà F, Pane C, Filla A, Marsili A, Puorro G, Lanzillo R, Brescia Morra V, Cortopassi G.

Hum Mol Genet. 2017 Aug 1;26(15):2864-2873. doi: 10.1093/hmg/ddx167.

31.

Prognostic indicators in pediatric clinically isolated syndrome.

Iaffaldano P, Simone M, Lucisano G, Ghezzi A, Coniglio G, Brescia Morra V, Salemi G, Patti F, Lugaresi A, Izquierdo G, Bergamaschi R, Cabrera-Gomez JA, Pozzilli C, Millefiorini E, Alroughani R, Boz C, Pucci E, Zimatore GB, Sola P, Lus G, Maimone D, Avolio C, Cocco E, Sajedi SA, Costantino G, Duquette P, Shaygannejad V, Petersen T, Fernández Bolaños R, Paolicelli D, Tortorella C, Spelman T, Margari L, Amato MP, Comi G, Butzkueven H, Trojano M; Italian iMedWeb Registry and the MSBase Registry.

Ann Neurol. 2017 May;81(5):729-739. doi: 10.1002/ana.24938.

PMID:
28439957
32.

Health-care disparities stemming from sexual orientation of Italian patients with Multiple Sclerosis: A cross-sectional web-based study.

Lavorgna L, Moccia M, Russo A, Palladino R, Riccio L, Lanzillo R, Brescia Morra V, Tedeschi G, Bonavita S.

Mult Scler Relat Disord. 2017 Apr;13:28-32. doi: 10.1016/j.msard.2017.02.001. Epub 2017 Feb 5.

33.

Alterations of functional connectivity of the motor cortex in Fabry disease: An RS-fMRI study.

Cocozza S, Pisani A, Olivo G, Saccà F, Ugga L, Riccio E, Migliaccio S, Brescia Morra V, Brunetti A, Quarantelli M, Tedeschi E.

Neurology. 2017 May 9;88(19):1822-1829. doi: 10.1212/WNL.0000000000003913. Epub 2017 Apr 12.

PMID:
28404798
34.

Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis.

Cocozza S, Olivo G, Riccio E, Russo C, Pontillo G, Ugga L, Migliaccio S, de Rosa D, Feriozzi S, Veroux M, Battaglia Y, Concolino D, Pieruzzi F, Tuttolomondo A, Caronia A, Russo CV, Lanzillo R, Brescia Morra V, Imbriaco M, Brunetti A, Tedeschi E, Pisani A.

Neuroradiology. 2017 Jun;59(6):563-570. doi: 10.1007/s00234-017-1829-8. Epub 2017 Apr 6.

PMID:
28386689
35.

Erratum: Antibodies from multiple sclerosis patients preferentially recognize hyperglucosylated adhesin of non-typeable Haemophilus influenzae.

Walvoort MT, Testa C, Eilam R, Aharoni R, Nuti F, Rossi G, Real-Fernandez F, Lanzillo R, Brescia Morra V, Lolli F, Rovero P, Imperiali B, Papini AM.

Sci Rep. 2017 Mar 22;7:44969. doi: 10.1038/srep44969. No abstract available.

36.

The importance of being persistent to multiple sclerosis treatments.

Moccia M, Lanzillo R, Cerullo G, De Rosa A, Brescia Morra V.

J Clin Neurosci. 2017 Jun;40:198-199. doi: 10.1016/j.jocn.2017.02.004. Epub 2017 Feb 27. No abstract available.

PMID:
28246007
37.

Healthcare Costs for Treating Relapsing Multiple Sclerosis and the Risk of Progression: A Retrospective Italian Cohort Study from 2001 to 2015.

Moccia M, Palladino R, Lanzillo R, Carotenuto A, Russo CV, Triassi M, Brescia Morra V.

PLoS One. 2017 Jan 5;12(1):e0169489. doi: 10.1371/journal.pone.0169489. eCollection 2017.

38.

Antibodies from multiple sclerosis patients preferentially recognize hyperglucosylated adhesin of non-typeable Haemophilus influenzae.

Walvoort MT, Testa C, Eilam R, Aharoni R, Nuti F, Rossi G, Real-Fernandez F, Lanzillo R, Brescia Morra V, Lolli F, Rovero P, Imperiali B, Papini AM.

Sci Rep. 2016 Dec 23;6:39430. doi: 10.1038/srep39430. Erratum in: Sci Rep. 2017 Mar 22;7:44969.

39.

Growth hormone/IGF-1 axis longitudinal evaluation in clinically isolated syndrome patients on interferon β-1b therapy: stimulation tests and correlations with clinical and radiological conversion to multiple sclerosis.

Lanzillo R, Di Somma C, Quarantelli M, Carotenuto A, Pivonello C, Moccia M, Cianflone A, Marsili A, Puorro G, Saccà F, Russo CV, De Luca Picione C, Ausiello F, Colao A, Brescia Morra V.

Eur J Neurol. 2017 Feb;24(2):446-449. doi: 10.1111/ene.13207. Epub 2016 Dec 16.

PMID:
27982500
40.

A longitudinal real-life comparison study of natalizumab and fingolimod.

Lanzillo R, Carotenuto A, Moccia M, Saccà F, Russo CV, Massarelli M, De Rosa A, Brescia Morra V.

Acta Neurol Scand. 2017 Sep;136(3):217-222. doi: 10.1111/ane.12718. Epub 2016 Dec 15.

PMID:
27976804
41.

Predictors of long-term interferon discontinuation in newly diagnosed relapsing multiple sclerosis.

Moccia M, Palladino R, Carotenuto A, Russo CV, Triassi M, Lanzillo R, Brescia Morra V.

Mult Scler Relat Disord. 2016 Nov;10:90-96. doi: 10.1016/j.msard.2016.09.011. Epub 2016 Sep 28.

PMID:
27919507
42.

Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis.

Prosperini L, Saccà F, Cordioli C, Cortese A, Buttari F, Pontecorvo S, Bianco A, Ruggieri S, Haggiag S, Brescia Morra V, Capra R, Centonze D, Di Battista G, Ferraro E, Francia A, Galgani S, Gasperini C, Millefiorini E, Mirabella M, Pozzilli C.

J Neurol. 2017 Feb;264(2):284-294. doi: 10.1007/s00415-016-8343-5. Epub 2016 Nov 22.

PMID:
27878443
43.

The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests.

Saccà F, Costabile T, Carotenuto A, Lanzillo R, Moccia M, Pane C, Russo CV, Barbarulo AM, Casertano S, Rossi F, Signoriello E, Lus G, Brescia Morra V.

Mult Scler. 2017 Aug;23(9):1289-1296. doi: 10.1177/1352458516677592. Epub 2016 Nov 3.

PMID:
27811338
44.

Grey:white matter ratio at diagnosis and the risk of 10-year multiple sclerosis progression.

Moccia M, Quarantelli M, Lanzillo R, Cocozza S, Carotenuto A, Carotenuto B, Alfano B, Prinster A, Triassi M, Nardone A, Palladino R, Brunetti A, Brescia Morra V.

Eur J Neurol. 2017 Jan;24(1):195-204. doi: 10.1111/ene.13183. Epub 2016 Nov 1.

PMID:
27801535
45.

Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy.

Laroni A, Brogi D, Brescia Morra V, Guidi L, Pozzilli C, Comi G, Lugaresi A, Turrini R, Raimondi D, Uccelli A, Mancardi GL.

Neurol Sci. 2017 Jan;38(1):53-59. doi: 10.1007/s10072-016-2701-z. Epub 2016 Oct 18.

PMID:
27757552
46.

Lamivudine and fingolimod co-administration in two patients with multiple sclerosis and occult hepatitis B virus infection.

Saccà F, Pane C, De Rosa A, Matarazzo M, Brescia Morra V.

Neurol Sci. 2017 Mar;38(3):501-502. doi: 10.1007/s10072-016-2726-3. Epub 2016 Oct 3. No abstract available.

PMID:
27699497
47.

The use of medical-grade cannabis in patients non-responders to Nabiximols.

Saccà F, Pane C, Carotenuto A, Massarelli M, Lanzillo R, Florio EB, Brescia Morra V.

J Neurol Sci. 2016 Sep 15;368:349-51. doi: 10.1016/j.jns.2016.07.059. Epub 2016 Jul 26. No abstract available.

PMID:
27538663
48.

Predictors of the 10-year direct costs for treating multiple sclerosis.

Moccia M, Palladino R, Lanzillo R, Triassi M, Brescia Morra V.

Acta Neurol Scand. 2017 May;135(5):522-528. doi: 10.1111/ane.12630. Epub 2016 Jun 29.

49.

Lack of correlation between extracranial venous abnormalities and multiple sclerosis: a quantitative MRI study.

Cocozza S, Canna A, Lanzillo R, Russo C, Postiglione E, Liuzzi R, Vastola M, Brunetti A, Salvatore M, Brescia Morra V, Palma G, Tedeschi E.

Br J Radiol. 2016 Jun 27:20160321. [Epub ahead of print]

50.

The Dress: Transforming a web viral event into a scientific survey.

Moccia M, Lavorgna L, Lanzillo R, Brescia Morra V, Tedeschi G, Bonavita S.

Mult Scler Relat Disord. 2016 May;7:41-6. doi: 10.1016/j.msard.2016.03.001. Epub 2016 Mar 4.

PMID:
27237755

Supplemental Content

Loading ...
Support Center